| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.72M | - | |
| Dir | 164.0K | $12.43M | -8,000 | |
| VP | 100.3K | $7.60M | - | |
| VP | 83.3K | $6.31M | -60,846 | |
| CFO | 82.7K | $6.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Swayze Eric63 | EVP Research | Sell | 6,179 | $82.93 | $512,446.10 | -11.5% | -9.6% | - | |
| Jan 30, 2026 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 6,179 | $83.53 | $516,153.50 | -7.9% | -9.6% | - | |
| Jan 30, 2026 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sell | 6,988 | $83.24 | $581,702.08 | -5.0% | -9.6% | - | |
| Jan 30, 2026 | Baroldi Joseph52 | EVP, Chief Business Officer | Sell | 5,296 | $82.96 | $439,364.10 | -10.4% | -9.6% | - | |
| Jan 30, 2026 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515,629.52 | -8.1% | -9.6% | - | |
| Jan 30, 2026 | Monia Brett P60 | Chief Executive Officer | Sell | 62,970 | $82.72 | $5,208,979.15 | -18.2% | -9.6% | - | |
| Jan 30, 2026 | Birchler Brian52 | EVP, Corp And Development Ops | Sell | 6,179 | $83.03 | $513,047.93 | -8.5% | -9.6% | - | |
| Jan 30, 2026 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 5,885 | $82.95 | $488,140.74 | -5.5% | -9.6% | - | |
| Jan 7, 2026 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sale+OE | 44,199 | $85.08 | $3,760,577.42 | -33.6% | -11.2% | - | |
| Jan 2, 2026 | Swayze Eric63 | EVP Research | Sale+OE | 23,463 | $79.12 | $1,856,324.51 | -27.8% | -6.1% | - |